2372 On Other Exchanges
2372 is not on other exchanges.

i'rom group co ltd (2372) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for I'ROM GROUP CO LTD (2372)

Related News

No related news articles were found.

i'rom group co ltd (2372) Related Businessweek News

No Related Businessweek News Found

i'rom group co ltd (2372) Details

I'rom Group Co., Ltd. provides clinical research organization and medical support services in Japan. The company supports medical facilities in executing clinical trials; and provides clinical trial support services for domestic and foreign pharmaceutical companies. It is also involved in the establishment and operation of medical malls; and technological licensing of regenerative medicine and gene therapy technology. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.

359 Employees
Last Reported Date: 06/28/16
Founded in 1997

i'rom group co ltd (2372) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

i'rom group co ltd
I'rom Group Co., Ltd., Q2 2017 Earnings Call, Nov 30, 2016

I'rom Group Co., Ltd., Q2 2017 Earnings Call, Nov 30, 2016

I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 2017

I'rom Group Co., Ltd. reported consolidated earnings results for the six months ended September 30, 2016. For the period, net sales were JPY 1,865 million against JPY 1,733 million a year ago. Operating loss was JPY 192 million against JPY 495 million a year ago. Ordinary loss was JPY 214 million against JPY 737 million a year ago. Net loss attributable to owners of parent was JPY 216 million against JPY 758 million a year ago. Net loss per share was JPY 20.39 against JPY 71.48 a year ago. For the fiscal year ending March 2017, on consolidated basis, the company expects net sales of JPY 7,200 million, operating income of JPY 600 million, ordinary income of JPY 700 million and net income attributable to owners of parent of JPY 500 million or JPY 47.12 per share.

I'rom Group Co., Ltd. to Report Q1, 2017 Results on Aug 10, 2016

I'rom Group Co., Ltd. announced that they will report Q1, 2017 results on Aug 10, 2016


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2372 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2372.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2372 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.5x
Price/Book 4.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact I'ROM GROUP CO LTD, please visit www.irom-hd.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.